Medipal Holdings
Basic Information
- Stock Code
- 7459
- Industry
- Wholesale
- Category Detail
- Pharmaceuticals & Medical Products Wholesalers
- Prefecture
- Tokyo
- Establishment Year
- May 1923
- Listing Year
- September 1995
- Official Website
- https://www.medipal.co.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Alfresa, Hokuyaku Takeyama Holdings, Vital KSK Holdings, Cosmo Bio, Ooki Healthcare Holdings, Solasia Pharma, Astena Holdings, Toho HD, Ko-A Trading Holdings, Suzuken
Overview
Medipal Holdings is the largest wholesaler in Japan's pharmaceutical and daily goods industry, founded in 1923. It is a holding company that develops a variety of related businesses centered on medical pharmaceutical wholesaling.
Current Situation
Medipal Holdings recorded consolidated revenue of 3.2909 trillion yen and net profit of 29.4 billion yen for the fiscal year ended March 2022, maintaining stable performance as the leading company in Japan's domestic pharmaceutical wholesaling industry. In addition to its core medical pharmaceutical wholesaling business, it has a diversified group structure including daily goods wholesaling through PALTAC and sales of veterinary pharmaceuticals and food processing raw materials. In recent years, it has focused on innovations such as IT-driven pharmaceutical logistics efficiency and investments in drug discovery ventures, while expanding its PMS business. It is also proactive in environmental and social contribution activities, promoting sustainable business operations in collaboration with local communities. It is strengthening competitiveness through internal system improvements and business alliances, with an eye toward growth after 2025. In 2023, it made Sumitomo Pharma Food & Chemical a wholly-owned subsidiary and Tohichi a subsidiary, working to expand its business foundation.
Trivia
Interesting Facts
- Originated from long-established pharmaceutical wholesaler founded in 1898
- Holds largest domestic share in medical pharmaceutical wholesaling
- PALTAC is a top-class player in daily goods wholesaling
- Employs over 12,800 people nationwide
- Collaborates with INCJ on drug discovery venture establishments
- Formulating and executing long-term logistics strategy '30-Year Plan'
- Expanding PMS business for medical sites with high expertise
- Deeply involved in distribution of Rohto Pharmaceutical's new products
- Leads industry in medical supplies database operations
- Proactive in pharmaceutical logistics efficiency via digitalization
- Flexible response to regional needs through regional subsidiaries
- Strong ties with medical professionals via insurance agency
- Expanding in veterinary pharmaceuticals centered in Hokkaido
- Expanding business domains through diverse capital and business alliances
- Company name derived from combination of former Mediseo and PALTAC
Hidden Connections
- Strong capital and transaction ties with major pharmaceutical companies like Takeda Pharmaceutical and Astellas Pharma
- Group companies participate in drug discovery ventures co-invested with INCJ
- Long history from original Kumada Sanmisodo Pharmacy builds trust in the industry
- Integrated Kobayashi Pharmaceutical's wholesaling subsidiary, gaining strength in beauty and cosmetics
- Advanced into digital medical field via capital and business alliance with MTI
- Highly responsive to regional market characteristics through subsidiary structure by area
- Leveraging Mitsubishi Corporation's financial strength and logistics network via business alliance
- Pioneering presence with dedicated subsidiary for PMS business of pharmaceutical products
Future Outlook
Growth Drivers
- Increasing demand for medical pharmaceuticals amid aging population
- Service diversification through medical and caregiving integration
- Acceleration of digital transformation
- New business expansion via drug discovery venture investments
- Logistics efficiency improvements emphasizing sustainability
- Strengthening regionally specialized pharmaceutical wholesaling
- Growth in veterinary pharmaceuticals market
- Expansion and high value-added transformation of medical PMS business
- Leveraging medical networks in insurance agency business
- Market share expansion opportunities from industry restructuring
- Strengthening strategic alliances with global pharmaceutical companies
- Business efficiency and service quality improvements via AI and IoT
Strategic Goals
- Achieve consolidated revenue of 5 trillion yen scale
- Realize carbon neutral in medical logistics
- Maintain top domestic share in PMS business
- Expand drug discovery support venture investment portfolio
- Achieve 70% logistics automation rate via DX technology introduction
- Complete nationwide construction of regionally focused pharmaceutical wholesaling network
- Become industry leader in veterinary pharmaceuticals
- Achieve 30% female manager ratio through diversity promotion
- Service innovation centered on customer satisfaction improvement
- Top-class ranking in ESG investment evaluations
Business Segments
Medical Pharmaceutical Wholesaling
- Overview
- Business providing medical pharmaceuticals and related products to hospitals and pharmacies.
- Competitiveness
- Possesses extensive sales network and specialized logistics systems.
- Customers
-
- Hospitals
- Pharmacies
- Medical Equipment Retailers
- Healthcare Facilities
- Products
-
- Medical Pharmaceuticals
- Medical Equipment
- Medical Supplies
- PMS Services
Cosmetics and Daily Goods Wholesaling
- Overview
- Stably supplies cosmetics and daily goods to retailers, maintaining industry share.
- Competitiveness
- Broad distribution channels and strong sales network.
- Customers
-
- Drugstores
- Supermarkets
- Specialty Stores
- Mail Order Businesses
- Products
-
- Cosmetics
- Toiletries
- Daily Goods
- Lifestyle Products
Veterinary Pharmaceuticals and Food Raw Materials Wholesaling
- Overview
- Business supplying veterinary pharmaceuticals and food processing raw materials, centered in Hokkaido.
- Competitiveness
- Regionally focused sales network and highly specialized product lineup.
- Customers
-
- Livestock Producers
- Pet Shops
- Food Processors
- Agribusiness Companies
- Products
-
- Veterinary Pharmaceuticals
- Food Additives
- Food Ingredients
Insurance Agency Operations
- Overview
- Solicitation and agency operations for insurance products targeted at medical professionals.
- Competitiveness
- Specialized product proposal capabilities in the medical industry
- Customers
-
- Medical Professionals
- Medical Institutions
- Products
-
- Property and Casualty Insurance
- Life Insurance
Competitive Advantage
Strengths
- Industry-leading pharmaceutical wholesaling network
- Diversified business portfolio
- Advanced pharmaceutical logistics systems
- Strong client relationships
- Synergies from extensive subsidiaries
- Highly specialized PMS business expansion
- Entry into regional veterinary pharmaceuticals market
- Strategic capital and business alliances
- Ample financial resources and stable financial base
- Advanced medical supplies database operations
- Diversification of medical-related services
- High brand power and industry recognition
- Extensive nationwide distribution network
- Sustainability initiatives
- Experience investing in new business ventures
Competitive Advantages
- Domestic largest-scale pharmaceutical wholesaling and nationwide coverage
- Broad product portfolio through group subsidiaries
- Highly efficient pharmaceutical logistics infrastructure utilizing IT
- Pioneering expansion in medical PMS business ahead of competitors
- Strong transaction relationships with medical institutions and pharmaceutical companies
- Synergy creation with diverse alliance partners
- Sales strategies tailored to regional characteristics nationwide
- Active investments in next-generation drug discovery ventures, etc.
- Management team's extensive industry experience and strategic decision-making
- Strengthened relationships with medical professionals via insurance agency
- Anticipating market needs with customer-focused services
- Reliability as a Prime Market-listed company
- Improved revenue stability through business diversification
- Proactive DX promotion and logistics efficiency efforts
- Enhanced corporate image through environmental and social contributions
Threats
- Intense price competition with rivals
- Risks from strengthened regulations and legal changes in pharmaceutical industry
- Market share erosion by new entrants
- Rising logistics costs and supply chain instability
- Transaction condition fluctuations due to structural changes in pharmaceutical industry
- Market contraction trends from population decline
- Declining profit margins from generic drug proliferation
- Supply disruptions from natural disasters or pandemics
- Competitiveness decline risks from digitalization delays
- Rising import costs from exchange rate fluctuations
- Cybersecurity risks
- Changes in competitive environment from industry restructuring
Innovations
2023: Full Acquisition of Sumitomo Pharma Food & Chemical
- Overview
- Acquired as subsidiary to expand food processing raw materials business.
- Impact
- Contributes to strengthening sales base in food-related wholesaling.
2022: Contracted Operations for Wound Treatment System 'AutoloGel System'
- Overview
- Contracted distribution of new Rohto Pharmaceutical product to strengthen medical logistics.
- Impact
- Contributes to business expansion in medical field.
2020: Established PMS-Specialized Subsidiary Fairfield
- Overview
- Integrated post-marketing surveillance business for pharmaceuticals to strengthen services.
- Impact
- Expands relationships with pharmaceutical manufacturers and enhances expertise.
2020: Business Alliance with Mirai Holdings in Medical and Healthcare
- Overview
- Aims to create synergies through strategic collaboration.
- Impact
- Strengthens new business development and market expansion.
2020: Formulated '30-Year Plan' for Pharmaceutical Logistics Efficiency
- Overview
- Initiated reforms to logistics systems from a long-term perspective.
- Impact
- Targets cost reductions and quality improvements.
2023: Full Acquisition of Tohichi
- Overview
- Strengthens pharmaceutical wholesaling business centered in Nagasaki Prefecture.
- Impact
- Expands regionally focused services and brand strength.
2021: Advancing Digitalization of Medical Pharmaceutical Wholesaling
- Overview
- Promotes business efficiency using AI and DX technologies.
- Impact
- Achieves significant improvements in logistics speed and cost reductions.
2023: Supported Establishment of Drug Discovery Venture Soquia Pharma
- Overview
- Participated jointly with INCJ and Takeda Pharmaceutical.
- Impact
- Builds foundation for business expansion through new technology creation.
2022: Enhanced Medical Supplies Database Services
- Overview
- Advanced data management technology deployed by subsidiary Medie.
- Impact
- Improves reliability and convenience of services for medical institutions.
2024: Initiated Plan to Smartize Logistics Systems
- Overview
- Logistics innovation through automation and robotics technology introduction.
- Impact
- Aims for personnel cost reductions and improved operational accuracy.
Sustainability
- Promoting activities to reduce environmental impact in pharmaceutical distribution
- Active participation in regional medical support programs
- Enhancing employee health management in line with work-style reforms
- Formulation and implementation of sustainable procurement policies
- Building emergency support systems for disasters
- CSR activities emphasizing coexistence with local communities
- Strengthening efforts to reduce plastic products
- Introducing energy-efficient logistics facilities
- Enhanced management to reduce medical waste
- Promoting diversity and inclusion